Medical Reps grounded: Will COVID-19 transform the face of the pharma industry for remote engagement permanently?
Face-to-face interactions shape the backbone of the pharmaceutical industry, even in today’s new technological age. One only needs to look at healthcare professionals (HCPs) to validate this – it’s Medical Representative (Med Rep) who spends most of his time interacting with HCPs in hospitals, clinics,
Tranz-Life shapes the environment for biological and biosimilar medicines in Pakistan
Biologic and biosimilar medicines, are major advancements in treatment for difficult-to-treat diseases; mainly in cancers, autoimmune and infectious diseases. The benefits of these drugs are not fully passed on to patients in Pakistan due to low awareness on the subject and delayed approvals from regulatory authorities for newer biologics.
Tranz-Life introduces AI-powered personalized care for Diabetes in Pakistan – Monitoring, Management & Treatment
Integrating Artificial Intelligence (AI) into the healthcare ecosystem has been projected to bring many breakthroughs in medicine; a notable example being the transformation of the diagnosis, prognosis and management of diabetic care.
Realities of medical research in Pakistan – apathy of the pharma industry and legislation
Isn’t that insane we are being treated with new medicines that have been clinically tested on populations other than our own? The dilemma continues – even widely used generics do not often undergo required quality testing of equivalence in human subjects unlike other countries where bio-equivalence studies are mandatory.
The valsartan API debacle – the way forward
In a world where globalism has allowed ideas to spread at phenomenal rates, novel drugs are becoming a rarity. Generics are rapidly filing our local pharmacy shelves – and while this is an auspicious development, providing high quality drugs at a lower cost – it is not without its pitfalls.The recent recall of many versions of valsartan formulations from many European countries
Tranz-Life brings Pakistan to the forefront of clinical research
KUALA LUMPUR, DEC 17 — Tranz-Life Pvt. and Jigsaw Clinical Research Solutions Sdn Bhd (JCRS) have entered into a strategic alliance where both organizations will collaborate in the provision of Clinical Research Services for the Pakistan and Bangladesh markets. These services include Clinical Trial Management,Laboratory Analysis, Medical Writing, and BA/BE studies